NasdaqGM - Nasdaq Real Time Price USD
Cartesian Therapeutics, Inc. (RNAC)
9.99
-0.20
(-2.01%)
As of 3:43:04 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-30,865
-23,674
-51,161
-31,631
-60,382
Investing Cash Flow
-9,215
-8,742
34,609
-15,002
-17,140
Financing Cash Flow
117,372
168,428
-13,145
39,215
52,897
End Cash Position
182,087
214,279
78,288
108,038
115,436
Interest Paid Supplemental Data
--
0
1,853
2,248
2,002
Capital Expenditure
-9,566
-9,093
-206
-1,201
-1,085
Issuance of Capital Stock
124,438
164,438
20,250
38,980
51,958
Issuance of Debt
--
--
--
0
0
Repayment of Debt
--
0
-27,457
0
0
Repurchase of Capital Stock
--
0
-6,169
0
0
Free Cash Flow
-40,431
-32,767
-51,367
-32,832
-61,467
12/31/2021 - 6/22/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BCYC Bicycle Therapeutics plc
8.00
-1.36%
EWTX Edgewise Therapeutics, Inc.
14.32
-3.83%
SYRE Spyre Therapeutics, Inc.
14.84
+0.58%
JANX Janux Therapeutics, Inc.
22.73
-10.27%
XNCR Xencor, Inc.
8.12
+0.12%
CNTA Centessa Pharmaceuticals plc
12.34
-0.96%
KYTX Kyverna Therapeutics, Inc.
2.1850
-5.82%
TCRX TScan Therapeutics, Inc.
1.3050
-1.88%
VRDN Viridian Therapeutics, Inc.
12.30
-4.02%
NRIX Nurix Therapeutics, Inc.
9.59
-1.44%